erythromycin has been researched along with Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beumont, M; Monshouwer, M; Ouwerkerk-Mahadevan, S; Snoeys, J | 1 |
| Craig, PI; Farrell, GC; Tapner, M | 1 |
2 other study(ies) available for erythromycin and Hepatitis C
| Article | Year |
|---|---|
Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach.
Topics: Alkynes; Antiviral Agents; Benzoxazines; Cyclopropanes; Cyclosporine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Erythromycin; Hepatitis C; Humans; Liver; Liver-Specific Organic Anion Transporter 1; Nonlinear Dynamics; Organic Anion Transporters; Rifampin; Ritonavir; Simeprevir; Viral Nonstructural Proteins | 2016 |
Interferon suppresses erythromycin metabolism in rats and human subjects.
Topics: Adult; Animals; Chronic Disease; Erythromycin; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Rats; Rats, Wistar; Recombinant Proteins; Reference Values | 1993 |